Marico Ltd
Marico Ltd
FMCG F&OKey Fundamentals
MidcapFMCG ProductsFMCGInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Marico Ltd insights
41 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company has a good return on equity (ROE) track record: 3 Years ROE 40.9%
- Company has been maintaining a healthy dividend payout of 65.1%
Weaknesses
2- Stock is trading at 26.3 times its book value
- The company has delivered a poor sales growth of 11.1% over past five years.
Growth Rate
AI Analysis — Bull vs Bear
Marico Ltd is a ₹1.11 lakh crore FMCG company trading at a PE of 56.7x and 26.3x book value, delivering FY25 consolidated revenue of ₹10,831 crore (up 12% YoY) and net profit of ₹1,629 crore. The company maintains a consistently high ROE of 41-43% and a 65% dividend payout, but faces near-term margin pressure from elevated copra and vegetable oil prices.
- Consistently high return on equity at 43% in the last year and a 3-year average of 41%, indicating efficient capital allocation
- Q4FY25 revenue grew 20% YoY to ₹2,730 crore, a 14-quarter high in consolidated revenue growth
- India business delivered 7% underlying volume growth in Q4FY25, demonstrating demand resilience beyond price-led growth
- International business posted 16% constant currency growth in Q4FY25, providing geographic diversification
- Healthy dividend payout ratio of 65.1% with a declared final dividend of ₹7 per share for FY25
- Compounded profit growth of 13% TTM and 10-year CAGR of 10%, showing long-term earnings consistency
- Near debt-free balance sheet with debt-to-equity ratio of approximately 0.14x, providing financial flexibility
- Stock CAGR of 20% over 1 year and 15% over 3 years, reflecting sustained market confidence
- Stock trades at 56.7x PE and 26.3x price-to-book, significantly above FMCG sector averages, leaving limited margin of safety
- Gross margin contracted approximately 300 bps YoY in Q4FY25 due to sharp rise in copra prices (up 38% YoY) and vegetable oil inflation
- EBITDA margin fell to 16.8% in Q4FY25, down 260 bps YoY, signalling near-term profitability pressure
- 5-year compounded sales growth of only 11% indicates moderate top-line expansion for a premium-valued FMCG company
- Net profit grew only 8% YoY in Q4FY25 to ₹343 crore despite 20% revenue growth, highlighting cost absorption challenges
- Dividend yield of just 0.47% offers minimal income return relative to the premium valuation
- Heavy dependence on coconut oil (Parachute) exposes earnings to volatile copra price cycles which are currently elevated
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Modern trade channel slowdown Aug 4
Marico executive flagged a modest slowdown in the modern trade channel, indicating a shift in near-term distribution dynamics. Company aims to sustain gross margins at prior-year levels in the short term.
- Q1FY27 profit jumps 25% YoY Aug 5
Marico reported consolidated net profit up 25% YoY to ₹630 crore for Q1FY27, beating analyst estimate of ₹590 crore. Revenue grew 23% to ₹3,957 crore with EBITDA margins expanding to 20.70%, driven by 11% India volume growth and 15% international CCG.
- High teen growth targeted by FY27 Aug 5
Marico outlined expectations of high teen revenue growth and better EBITDA margins by FY27, with double-digit volume growth anticipated in Q2FY27.
- ₹44 crore block trade on BSE Jul 28
Marico recorded a block trade of ~5.12 lakh shares at ₹866.50 per share on BSE, totaling ₹44.33 crore, reflecting institutional-level activity.
- Q1FY27 earnings call scheduled Jul 27
Marico hosted investor conference call on August 4, 2026 to discuss Q1FY27 results and operational updates.
TL;DR: Marico delivered its strongest quarterly profit growth in 28 quarters with Q1FY27 net profit up 25% to ₹630 crore, beating estimates across revenue, EBITDA, and margins. Volume growth of 11% domestically and 15% internationally signals healthy demand. The only near-term concern is a modest slowdown in the modern trade channel. Overall trend is clearly improving, with management guiding for high teen growth and margin expansion through FY27.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,477 | 2,476 | 2,422 | 2,278 | 2,643 | 2,664 | 2,794 | 2,730 | 3,221 | 3,482 | 3,537 | 3,301 | 3,957 |
| Expenses | 1,903 | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,566 | 2,922 | 2,945 | 2,780 | 3,138 |
| Operating Profit | 574 | 497 | 513 | 442 | 626 | 522 | 533 | 458 | 655 | 560 | 592 | 521 | 819 |
| OPM % | 23% | 20% | 21% | 19% | 24% | 20% | 19% | 17% | 20% | 16% | 17% | 16% | 21% |
| Other Income | 46 | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 | 39 | 60 | 48 |
| Interest | 17 | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 | 14 | 17 | 21 |
| Depreciation | 36 | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 | 50 | 60 | 56 |
| PBT | 567 | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 | 567 | 504 | 790 |
| Tax % | 23% | 24% | 22% | 20% | 22% | 22% | 22% | 22% | 22% | 21% | 19% | 19% | 17% |
| Net Profit | 436 | 360 | 386 | 320 | 474 | 433 | 406 | 345 | 513 | 432 | 460 | 408 | 652 |
| EPS in Rs | 3.3 | 2.73 | 2.96 | 2.46 | 3.58 | 3.27 | 3.08 | 2.65 | 3.89 | 3.24 | 3.44 | 3.01 | 4.85 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,733 | 6,017 | 5,918 | 6,322 | 7,334 | 7,315 | 8,048 | 9,512 | 9,764 | 9,653 | 10,831 | 13,611 | 14,277 |
| Expenses | 4,863 | 4,966 | 4,759 | 5,185 | 6,009 | 5,846 | 6,459 | 7,831 | 7,954 | 7,627 | 8,692 | 11,283 | 11,785 |
| Operating Profit | 870 | 1,051 | 1,159 | 1,137 | 1,325 | 1,469 | 1,589 | 1,681 | 1,810 | 2,026 | 2,139 | 2,328 | 2,492 |
| OPM % | 15% | 17% | 20% | 18% | 18% | 20% | 20% | 18% | 19% | 21% | 20% | 17% | 17% |
| Other Income | 59 | 93 | 96 | 85 | 103 | 95 | 107 | 98 | 144 | 142 | 208 | 204 | 196 |
| Interest | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 53 | 64 |
| Depreciation | 84 | 95 | 90 | 89 | 131 | 140 | 139 | 139 | 155 | 158 | 178 | 202 | 213 |
| PBT | 822 | 1,029 | 1,149 | 1,117 | 1,257 | 1,374 | 1,523 | 1,601 | 1,743 | 1,937 | 2,116 | 2,277 | 2,411 |
| Tax % | 29% | 30% | 29% | 26% | 10% | 24% | 21% | 22% | 24% | 22% | 22% | 20% | — |
| Net Profit | 585 | 723 | 811 | 827 | 1,131 | 1,043 | 1,199 | 1,255 | 1,322 | 1,502 | 1,658 | 1,813 | 1,952 |
| EPS in Rs | 4.45 | 5.51 | 6.19 | 6.31 | 8.63 | 7.91 | 9.08 | 9.48 | 10.07 | 11.44 | 12.57 | 13.57 | 14.54 |
| Div. Payout % | 28% | 77% | 57% | 67% | 55% | 85% | 83% | 97% | 45% | 83% | 83% | 30% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 64 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 130 |
| Reserves | 1,760 | 1,888 | 2,197 | 2,414 | 2,846 | 2,894 | 3,111 | 3,219 | 3,670 | 3,703 | 3,846 | 4,080 |
| Borrowings | 428 | 331 | 239 | 312 | 352 | 338 | 511 | 479 | 608 | 528 | 554 | 557 |
| Other Liabilities | 873 | 1,010 | 1,059 | 1,217 | 1,569 | 1,603 | 1,675 | 1,850 | 2,393 | 2,993 | 3,746 | 5,183 |
| Total Liabilities | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,275 | 9,950 |
| Fixed Assets | 1,076 | 1,050 | 1,085 | 1,110 | 1,300 | 1,396 | 1,612 | 1,760 | 2,246 | 2,724 | 2,758 | 3,633 |
| CWIP | 3 | 37 | 11 | 27 | 45 | 58 | 24 | 39 | 67 | 44 | 40 | 85 |
| Investments | 284 | 544 | 608 | 543 | 450 | 733 | 854 | 828 | 1,096 | 602 | 1,590 | 2,083 |
| Other Assets | 1,763 | 1,727 | 1,919 | 2,392 | 3,101 | 2,777 | 2,936 | 3,050 | 3,391 | 3,983 | 3,887 | 4,149 |
| Total Assets | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,275 | 9,950 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 665 | 818 | 649 | 516 | 1,062 | 1,214 | 2,007 | 1,016 | 1,419 | 1,387 | 1,363 | 2,084 |
| Investing | -186 | -203 | -125 | 59 | -367 | -22 | -933 | 441 | -928 | 176 | -621 | -722 |
| Financing | -625 | -601 | -574 | -567 | -698 | -1,147 | -1,058 | -1,290 | -560 | -1,542 | -649 | -1,279 |
| Net Cash Flow | -147 | 14 | -51 | 8 | -3 | 45 | 16 | 167 | -69 | 21 | 93 | 83 |
| Free Cash Flow | 607 | 731 | 567 | 388 | 919 | 1,034 | 1,870 | 884 | 1,237 | 1,234 | 1,241 | 1,772 |
| CFO/OP | 101 | 101 | 82 | 71 | 104 | 102 | 144 | 81 | 99 | 87 | 86 | 114 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 15 | 15 | 20 | 26 | 27 | 18 | 25 | 38 | 40 | 43 | 35 |
| Inventory Days | 139 | 110 | 193 | 190 | 147 | 157 | 108 | 106 | 94 | 116 | 93 | 85 |
| Days Payable | 79 | 80 | 107 | 103 | 98 | 108 | 109 | 101 | 112 | 137 | 103 | 108 |
| Cash Conversion Cycle | 71 | 46 | 101 | 106 | 74 | 76 | 17 | 30 | 20 | 19 | 33 | 12 |
| Working Capital Days | 18 | 0 | 23 | 37 | 27 | 24 | -11 | 5 | 2 | 14 | 16 | -18 |
| ROCE % | 38% | 44% | 45% | 42% | 42% | 43% | 43% | 43% | 42% | 43% | 45% | 47% |
Documents
Frequently Asked Questions about Marico Ltd
What does Marico Ltd do?
Where is Marico Ltd (MARICO) listed?
Which sector does Marico Ltd belong to?
What is the market capitalisation of Marico Ltd?
What is the PE ratio of Marico Ltd?
What is the 52-week high and low of Marico Ltd?
Does Marico Ltd pay dividends?
What is the Return on Equity (ROE) of Marico Ltd?
How can I research Marico Ltd on Tapetide?
Company Information
Marico Limited is one of India's leading consumer goods companies, operating across beauty, personal care, wellness and foods in India and select international markets. Portfolio includes Parachute, Saffola, Hair & Care, Nihar, Livon, Set Wet, Beardo, Just Herbs, True Elements, Plix, Cosmix and 4700BC; products reach 1 out of 3 Indians.[1]